Methods for measuring proteasome activity: current limitations and future developments.

@article{Liggett2010MethodsFM,
  title={Methods for measuring proteasome activity: current limitations and future developments.},
  author={Alan Liggett and Lisa Judith-Ann Crawford and Barry Walker and T C M 'curly' Morris and Alexandra Elizabeth Irvine},
  journal={Leukemia research},
  year={2010},
  volume={34 11},
  pages={1403-9}
}
The proteasome has been validated as a therapeutic target, with proteasome inhibitors showing particular efficacy in the treatment of Multiple Myeloma. A wide range of methods have been developed to profile proteasome activity. These include the current method of choice fluorogenic peptide substrates, as well as bioluminescent imaging, immunological methods, and more recently, site-specific fluorescent probes. The aim of this review is to evaluate the currently available methods for profiling… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Azido - BODIPYacid reveals quantitative Staudinger – Bertozzi ligation in two - step activity - based proteasome profiling

  • VerdoesM, BI Florea, U Hillaert, LI Willems, van der LindenWA, Sae-HengM
  • Chem Biol Chem
  • 2008

Borte - zomib ( Velcade ) induces p 27 Kip 1 expression through S - phase kinase protein 2 degradation in colorectal cancer

  • RC Kane, PF Bross, AT Farell, R Pazadur
  • Cancer Res
  • 2008

Purification and proteomic analysis of 20 S pro - teasomes from human cells

  • M Ducoux-Petit, S Uttenweiler-Joseph, F Brichory, MP Bousquet-Dubouch, O Burlet-Schiltz, JF Haeuw
  • Methods Mol Biol
  • 2008

Similar Papers

Loading similar papers…